Solid organ transplant donors with central nervous system infection

Daniel R Kaul1, Shandie Covington, Sarah Taranto

  • 11 Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, MI. 2 United Network for Organ Sharing, Richmond, VA. 3 Department of Pediatrics and Surgery, Division of Pediatric Infectious Diseases, University of Pittsburgh Medical School, Pittsburgh, PA. 4 Department of Internal Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA. 5 Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix, AZ. 6 Department of Internal Medicine, Division of Infectious Diseases, University of Iowa Carver College of Medicine, Iowa City, IA. 7 Department of Medicine, Division of Infectious Disease, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA. 8 Address correspondence to: Daniel R. Kaul, M.D., Division of Infectious Diseases, University of Michigan Medical Center, 3120 Taubman Center, 1500 E. Medical Center Dr., SPC 5378, Ann Arbor, MI.

Transplantation
|June 11, 2014
PubMed

Insights

Donor-derived infections (DDI) from central nervous system (CNS) pathogens are rare but serious. A review found that 12 donors had CNS infections, with six transmitting to recipients, causing severe disease and deaths.

Area of Science:

  • Transplant Immunology
  • Infectious Diseases
  • Neurology

Background:

  • Donor-derived infections (DDI) from central nervous system (CNS) pathogens, though uncommon, pose significant risks to organ recipients.
  • Reports indicate DDI with CNS pathogens can lead to severe recipient morbidity and mortality.
  • The Ad Hoc Disease Transmission Advisory Committee (DTAC) analyzed potential donor-derived disease transmission events (PDDTE) to characterize donors and outcomes related to CNS pathogen DDI.

Purpose of the Study:

  • To describe donor characteristics associated with DDI from CNS pathogens.
  • To outline recipient outcomes following DDI from CNS pathogens.
  • To identify risk factors and warning signs for CNS pathogen transmission from donors.

Main Methods:

  • Review of all PDDTE reported between January 2008 and September 2010.
  • Identification of cases with suspected CNS infection in either donor or recipient.
  • Detailed examination of confirmed donor CNS infections and subsequent recipient infections.

Main Results:

  • Ninety-one PDDTE cases with suspected CNS infection were identified.
  • Twelve donors had confirmed CNS infections; six transmitted to 10 of 15 recipients.
  • Five recipient deaths occurred; implicated pathogens included Balamuthia mandrillaris, Cryptococcus neoformans, LCMV, and West Nile virus.

Conclusions:

  • Careful clinical assessment of organ donors is crucial for preventing DDI.
  • A high index of suspicion for ambiguous findings suggestive of CNS infection is necessary.
  • While risk reduction is possible, complete elimination of DDI from CNS pathogens remains challenging.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
826
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
64.4K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
925